FI951092A0 - Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet - Google Patents

Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet

Info

Publication number
FI951092A0
FI951092A0 FI951092A FI951092A FI951092A0 FI 951092 A0 FI951092 A0 FI 951092A0 FI 951092 A FI951092 A FI 951092A FI 951092 A FI951092 A FI 951092A FI 951092 A0 FI951092 A0 FI 951092A0
Authority
FI
Finland
Prior art keywords
stable
highly concentrated
fluorescein derivatives
concentrated preparations
preparations
Prior art date
Application number
FI951092A
Other languages
English (en)
Swedish (sv)
Other versions
FI951092A (fi
Inventor
Gyoergy Lajos Kis
Ernst Dieter Wachsmuth
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI951092A0 publication Critical patent/FI951092A0/fi
Publication of FI951092A publication Critical patent/FI951092A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951092A 1992-09-10 1995-03-08 Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet FI951092A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92810695 1992-09-10
PCT/EP1993/002367 WO1994005331A1 (de) 1992-09-10 1993-09-02 Stabile hochkonzentrierte formulierungen von fluoresceinderivaten

Publications (2)

Publication Number Publication Date
FI951092A0 true FI951092A0 (fi) 1995-03-08
FI951092A FI951092A (fi) 1995-03-08

Family

ID=8211984

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951092A FI951092A (fi) 1992-09-10 1995-03-08 Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet

Country Status (9)

Country Link
US (1) US5573773A (fi)
EP (1) EP0663838A1 (fi)
JP (1) JPH08503928A (fi)
KR (1) KR950703365A (fi)
AU (1) AU4956193A (fi)
CA (1) CA2143115A1 (fi)
FI (1) FI951092A (fi)
TW (1) TW251236B (fi)
WO (1) WO1994005331A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390668B2 (en) * 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US7026166B2 (en) * 2002-01-22 2006-04-11 Chiron Corporation Fluorogenic dyes
US7704756B2 (en) * 2003-01-21 2010-04-27 Novartis Vaccines And Diagnostics, Inc. Fluorogenic dyes
ES2523454T3 (es) * 2003-06-16 2014-11-26 Solx, Inc. Derivación para el tratamiento del glaucoma
JP2007518539A (ja) * 2004-01-22 2007-07-12 ソルクス・インコーポレーテッド 緑内障の治療方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
FR2611141B1 (fr) * 1987-02-20 1991-02-01 Int Rech Cancer Centre Ensemble ou kit pour utilisation comme agent pour la destruction selective de cellules transformees ou tumorales
US5227372A (en) * 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues

Also Published As

Publication number Publication date
US5573773A (en) 1996-11-12
JPH08503928A (ja) 1996-04-30
KR950703365A (ko) 1995-09-20
AU4956193A (en) 1994-03-29
EP0663838A1 (de) 1995-07-26
TW251236B (fi) 1995-07-11
WO1994005331A1 (de) 1994-03-17
FI951092A (fi) 1995-03-08
CA2143115A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
ATE209916T1 (de) Orale zubereitungen von antimykotika
ATA75293A (de) Indolderivate
NL300035I1 (nl) Gesubstitueerde thiahzolidinedionderivaten.
ATA165489A (de) Nitroglycerinhaltige spray-präparate
DE69314641D1 (de) Haarkosmetisches präparat
ATE118767T1 (de) 3-substituierte-2-oxindolderivate als entzündungshemmender.
DE69330497D1 (de) Chinazolin-derivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
MX9205003A (es) Derivados novedosos de benzopirano.
NO930781D0 (no) Vandige farmasoeytiske preparater av natriumkromoglykat
FI951092A (fi) Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
MX9204370A (es) Derivados de pirazol.
FI912963A0 (fi) Hjaernverksamheten oekande pyrimidinylderivat.
FI953106A (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
MX9201931A (es) Nuevos derivados de tiazol.
MX9205973A (es) Derivados de benzo-isoquinolinas.
NO950646D0 (no) Stabile, meget konsentrerte preparater av fluorescein-derivater
NO892470L (no) Fremstilling av laktolderivater.
FI904673A0 (fi) 2,6-dioksopiperidiinijohdannaisten valmistus
FI950101A (fi) 4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
LV5046A3 (lv) 3-(2,2,2-trimetilhidrazinij)propionata dihidrata iegusanas panemiens
BR9306699A (pt) Derivados do triazoliletanol

Legal Events

Date Code Title Description
FD Application lapsed